Nuzenio

Zntl Aug

Zntl Aug news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 13 latest news signals 6 publisher sources 100/100 entity strength

Latest news

ZNTL260821P00002500 interactive stock chart | ZNTL Aug 2026 2.500 put stock - Yahoo Finance SingaporeYahoo Finance Singapore · Sun, 09 Aug 2026 17:43:22 GMTZentalis Pharmaceuticals, Inc. Stock 12‑Month Price Target Raised to $7.44, Implies 49% Upside - TradingViewTradingView · Fri, 07 Aug 2026 17:20:35 GMTZNTL Advances Clinical Trials for Ovarian Cancer Drug Amid Valua - GuruFocusGuruFocus · Thu, 06 Aug 2026 23:38:12 GMTZentalis Pharmaceuticals, Inc. 2Q 2026: Net loss $(42.3M), EPS $(0.59) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 20:36:00 GMTZNTL: Q2 2026 net loss widened to $42.3M as R&D spending rose for late-stage azenosertib trials - TradingViewTradingView · Thu, 06 Aug 2026 20:18:19 GMTZNTL: Clinical and regulatory progress advances, with $174.6M cash runway into late 2027 despite higher losses - TradingViewTradingView · Thu, 06 Aug 2026 09:02:20 GMTZNTL 8-K & SEC Filings - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 07:00:00 GMTBlackRock, Inc. Expands Stake in Zentalis Pharmaceuticals (ZNTL) with Strategic Share Addition - GuruFocusGuruFocus · Thu, 06 Aug 2026 02:10:22 GMT

Timeline

Sun, 09 Aug 2026 17:43:22 GMTZNTL260821P00002500 interactive stock chart | ZNTL Aug 2026 2.500 put stock - Yahoo Finance Singapore
Fri, 07 Aug 2026 17:20:35 GMTZentalis Pharmaceuticals, Inc. Stock 12‑Month Price Target Raised to $7.44, Implies 49% Upside - TradingView
Thu, 06 Aug 2026 23:38:12 GMTZNTL Advances Clinical Trials for Ovarian Cancer Drug Amid Valua - GuruFocus
Thu, 06 Aug 2026 20:36:00 GMTZentalis Pharmaceuticals, Inc. 2Q 2026: Net loss $(42.3M), EPS $(0.59) — 10-Q Summary - TradingView
Thu, 06 Aug 2026 20:18:19 GMTZNTL: Q2 2026 net loss widened to $42.3M as R&D spending rose for late-stage azenosertib trials - TradingView
Thu, 06 Aug 2026 09:02:20 GMTZNTL: Clinical and regulatory progress advances, with $174.6M cash runway into late 2027 despite higher losses - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Zntl Aug.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.